Allogene Therapeutics, Inc. (ALLO) Earnings
|
Expand Research on ALLO
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +11.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -5.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/12/26  |
Q425 | N/A | -$0.23 | N/A | N/A | $2.22K | N/A | N/A | N/A | ||
| 10/30/25 |
Q325 | N/A | -$0.22 | N/A | N/A | $2.22K | N/A | N/A | N/A | ||
| 11/6/25 | Q325 | -$0.19 | -$0.22 | +$0.03 | N/A | $2.22K | N/A |  | | Details | |
| 8/13/25 | Q225 | -$0.23 | -$0.27 | +$0.04 | N/A | N/A | N/A | | | Details | |
| 8/6/25 |
Q225 | N/A | -$0.27 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/13/25 |
Q125 | N/A | -$0.29 | N/A | N/A | $2.22K | N/A | N/A | N/A | ||
| 5/6/25 |
Q125 | N/A | -$0.29 | N/A | N/A | $2.22K | N/A | N/A | N/A | ||
| 5/5/25 |
Q125 | N/A | -$0.29 | N/A | N/A | $2.22K | N/A | N/A | N/A |
